---
title: Research Project Led by Gifu Pharmaceutical University’s Associate Professor Shinsuke Nakamura, Supported by OUVC, Selected for the Tongali GAP Fund Program STEP 2
image: https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/ogp.png
description: Research Project Led by Gifu Pharmaceutical University’s Associate Professor Shinsuke Nakamura, Supported by OUVC, Selected for the Tongali GAP Fund Program STEP 2
---

[![](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/header_logo.svg)](https://www.ouvc.co.jp/en/?hsLang=en)

- [ABOUT US](https://www.ouvc.co.jp/en/aboutus?hsLang=en)
  
    - [![](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/headerBtn_company.jpg) COMPANY](https://www.ouvc.co.jp/en/aboutus?hsLang=en)
    - [![](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/headerBtn_fund.jpg) FUND](https://www.ouvc.co.jp/en/fund?hsLang=en)
- [NEWS](https://blog.ouvc.co.jp/en/)
- [PORTFOLIO](https://www.ouvc.co.jp/en/portfolio?hsLang=en)
- [MEMBER](https://www.ouvc.co.jp/en/member?hsLang=en)
- [CONTACT](https://www.ouvc.co.jp/en/contact?hsLang=en)
- [JP](https://blog.ouvc.co.jp/topics/261001-0?hsLang=ja)/EN

[JP](https://blog.ouvc.co.jp/topics/261001-0?hsLang=ja)/EN

[![](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/header_logo.svg)](https://www.ouvc.co.jp/en/?hsLang=en)

- [ABOUT US](https://www.ouvc.co.jp/en/aboutus?hsLang=en) 
    - [COMPANY](https://www.ouvc.co.jp/en/aboutus?hsLang=en)
    - [FUND](https://www.ouvc.co.jp/en/fund?hsLang=en)

- [NEWS](https://blog.ouvc.co.jp/?hsLang=en)

- [PORTFOLIO](https://www.ouvc.co.jp/en/portfolio?hsLang=en)

- [MEMBER](https://www.ouvc.co.jp/en/member?hsLang=en)

- [CONTACT](https://www.ouvc.co.jp/en/contact?hsLang=en)

## NEWS

[HOME](https://www.ouvc.co.jp/?hsLang=en) [NEWS](https://blog.ouvc.co.jp/?hsLang=en) Research Project Led by Gifu Pharmaceutical University’s Associate Professor Shinsuke Nakamura, Supported by OUVC, Selected for the Tongali GAP Fund Program STEP 2

## Research Project Led by Gifu Pharmaceutical University’s Associate Professor Shinsuke Nakamura, Supported by OUVC, Selected for the Tongali GAP Fund Program STEP 2

2026.10.01

[news](https://blog.ouvc.co.jp/en/tag/news)

### OUVCが事業化推進機関として支援

　大阪大学ベンチャーキャピタル株式会社（以下「OUVC」）が事業化推進機関として支援する、岐阜薬科大学 中村信介准教授の研究開発課題「新生血管型加齢黄斑変性に対するDual Function型抗HB-EGF抗体医薬創製」が、令和8（2026）年度 「Tongali GAPファンドプログラム STEP2」に採択されました。

　OUVCは、本研究シーズの事業化に向け、中村准教授および岐阜薬科大学と連携し、研究開発計画、知財・事業戦略、臨床開発計画、事業化体制の構築などを支援してまいります。

　大学発の優れた研究成果を社会実装につなげるため、今後も事業化推進機関として伴走支援を行い、本研究シーズの事業化を推進してまいります。

 

採択課題

研究代表者：中村 信介 准教授（岐阜薬科大学）  
事業化推進機関：大阪大学ベンチャーキャピタル株式会社  
研究テーマ：新生血管型加齢黄斑変性に対するDual Function型抗HB-EGF抗体医薬創製

※Tongaliによる採択発表は、以下をご覧ください。

[https://tongali.net/news/tongali-x/31477/](https://tongali.net/news/tongali-x/31477/)

 

[Prev](https://blog.ouvc.co.jp/en/topics/260924-0?hsLang=en)

[Back to List](https://blog.ouvc.co.jp/en/)

### Related Posts

- [![noimage](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/noimage.png) 2026.10.01 Research Project Led by Gifu Pharmaceutical University’s Associate Professor Shinsuke Nakamura, Supported by OUVC, Selected for the Tongali GAP Fund Program STEP 2](https://blog.ouvc.co.jp/en/topics/261001-0)
- [![noimage](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/noimage.png) 2026.06.16 Venture Capitalist Shigehiro Asano Spoke at a Panel Discussion at the Life Science × Acceleration Forum 2026](https://blog.ouvc.co.jp/en/topics/260616?hsLang=en)
- [![noimage](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/noimage.png) 2026.05.22 Three Technologies from The University of Osaka Selected for the 3rd KSAC GAP Fund — OUVC to Support Commercialization of a Sulfur Polymer, Heart Failure Drug, and Osteoporosis Treatment Device](https://blog.ouvc.co.jp/en/topics/260522-0?hsLang=en)

[![](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/footer__logo.svg)](https://www.ouvc.co.jp/en/?hsLang=en)

 OSAKA University Venture Capital  
 3F, TechnoAlliance Complex,   
 2-8 Yamadaoka,  
 Suita City Osaka 565-0871

<https://www.facebook.com/OsakaUniversityVentureCapital/>

### CONTACT

 Please feel free to contact us for a consultation.

[CONTACT](https://www.ouvc.co.jp/en/contact?hsLang=en)

[ABOUT US](https://www.ouvc.co.jp/en/aboutus?hsLang=en)

[COMPANY](https://www.ouvc.co.jp/en/aboutus?hsLang=en) [FUND](https://www.ouvc.co.jp/en/fund?hsLang=en)

[PORTFOLIO](https://www.ouvc.co.jp/en/portfolio?hsLang=en)

[MEMBER](https://www.ouvc.co.jp/en/member?hsLang=en)

[CONTACT](https://www.ouvc.co.jp/en/contact?hsLang=en)

[THE UNIVERSITY OF OSAKA](https://www.osaka-u.ac.jp/ja) [Co-Creation Bureau, the University of Osaka](https://www.ccb.osaka-u.ac.jp) [FUND COORDINATION](https://www.ouvc.co.jp/en/link?hsLang=en)

 Copyright 2023 OSAKA University Venture Capital Co., Ltd. All Rights Reserved. 

[CORPORATE POLICIES](https://connect.ouvc.co.jp/en/corporate-policies?hsLang=en)

![](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/arrow_top.svg)